Efficacy and Safety of Trastuzumab Combined with Pertuzumab for Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer: A Meta-Analysis Study of Randomized Control Trials

Figure 6

Meta-analysis of the incidence of systemic adverse reactions after treatment in the two groups of patients. (a) Forest plot of neutropenia. (b) Forest plot of fatigue. (c) Forest plot of rash. (d) Forest plot of myalgia. (e) Forest plot of all cardiac disorders.

(a)

(b)

(c)

(d)

(e)